Theragnostic Imaging
Theragnostic Imaging
News
People
Events
Publications
RNTreg
Contact
Article-Journal
Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study
No abstract available
Monika Kvassheim
,
Mona-Elisabeth R Revheim
,
Caroline Stokke
Oct 10, 2022
Cite
DOI
Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
[
18
F]FDG PET/CT in multiple myeloma (MM) is currently the best technology to demonstrate patchy and extramedullary disease. However, [ …
Caroline Stokke
,
Jakob Nordberg Nørgaard
,
Hilde Feiring Phillips
,
Alexander Sherwani
,
Syed Nuruddin
,
James Connelly
,
Fredrik Schjesvold
,
Mona-Elisabeth Revheim
Oct 1, 2022
Cite
DOI
FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
[
177
Lu]Lu-lilotomab satetraxetan, a novel CD37 directed radioimmunotherapy (RIT), has been investigated in a first-in-human phase 1/2a …
Ayca Løndalen
,
Johan Blakkisrud
,
Mona-Elisabeth Revheim
,
Jostein Dahle
,
Arne Kolstad
,
Caroline Stokke
Oct 1, 2022
Cite
DOI
Radionuclides for Targeted Therapy: Physical Properties
A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As …
Caroline Stokke
,
Monika Kvassheim
,
Johan Blakkisrud
Aug 25, 2022
Cite
DOI
Quantitative SPECT/CT imaging of lead-212: a phantom study
Lead-212 (
212
Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 (
212
Bi) via …
Monika Kvassheim
,
Mona-Elisabeth R Revheim
,
Caroline Stokke
Aug 4, 2022
Cite
DOI
Mucosa-sparing dose painting of head and neck cancer
No abstract available
Morten Egeberg Evensen
,
Torbjørn Furre
,
Eirik Malinen
,
Ayca Muftuler Løndalen
,
Einar Dale
Feb 1, 2022
Cite
DOI
Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI
Accurate target volume delineation is a prerequisite for high-precision radiotherapy. However, manual delineation is resource-demanding …
Aurora Rosvoll Groendahl
,
Yngve Mardal Moe
,
Christine Kiran Kaushal
,
Bao Ngoc Huynh
,
Espen Rusten
,
Oliver Tomic
,
Eivor Hernes
,
Bettina Hanekamp
,
Christine Undseth
,
Marianne Grønlie Guren
,
Eirik Malinen
,
Cecilia Marie Futsaether
Jan 1, 2022
Cite
DOI
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
18
F-flutemetamol positron emission tomography (PET) is used to assess cortical amyloid-β burden in patients with cognitive impairment …
Ebba Gløersen Müller
,
Caroline Stokke
,
Henning Langen Stokmo
,
Trine Holt Edwin
,
Anne-Brita Knapskog
,
Mona-Elisabeth Revheim
Jan 1, 2022
Cite
DOI
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
Patients with Alzheimer’s disease (AD) show heterogeneity in clinical progression rate, and we have limited tools to predict …
Ebba Gløersen Müller
,
Trine Holt Edwin
,
Bjørn Heine Strand
,
Caroline Stokke
,
Mona-Elisabeth Revheim
,
Anne-Brita Knapskog
Jan 1, 2022
Cite
DOI
EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
The aim of this standard operational procedure is to standardize the methodology employed for the evaluation of pre- and post-treatment …
Carlo Chiesa
,
Katarina Sjogreen Gleisner
,
Stephan Walrand
,
Lidia Strigari
,
Glenn Flux
,
Jonathan Gear
,
Caroline Stokke
,
Pablo Minguez Gabina
,
Peter Bernhardt
,
Mark Konijnenberg
Nov 12, 2021
Cite
DOI
«
»